Humana's Q2 2025 earnings showcase raised EPS guidance, driven by CenterWell Pharmacy outperformance and MA membership gains.

The prior authorization process is in the spotlight as the majority of Americans say delays and denials of services and ...

Humana CEO Jim Rechtin said "we are executing against our plan.” Billions at stake in Humana legal battle Humana to offer ...

The health insurer’s results are a bright spot in what’s otherwise been a gloomy quarter for the sector. Humana says it has a ...

Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally ...

EyeMed offers three plan tiers: Healthy, Bold and Bright. Healthy, its most affordable option at just $5 per month, covers an annual vision exam without a copayment and offers discounts on frames (35% ...

Humana's growth trajectory could rebound from current weakness, with management calling for pretax profits to more than double from 2025 to 2028 and grow in the low double digits in the long run at ...

Humana raised its annual profit forecast after beating quarterly estimates on Wednesday, as the U.S. health insurer succeeded ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Hit by rising medical care costs and squeezed by government changes, the health care conglomerate acknowledges “pricing and operational mistakes” affected its bottom line and has outlined steps to ...

Humana Inc. (HUM) raised its full-year earnings outlook on Wednesday after reporting better-than-expected results for the ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.